Home Amines 183721-15-5
183721-15-5,MFCD01321046
Catalog No.:AA00AE8U

183721-15-5 | 9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%(HPLC)
in stock  
$481.00   $337.00
- +
10mg
≥98%(HPLC)
in stock  
$729.00   $510.00
- +
25mg
≥98%(HPLC)
in stock  
$1,400.00   $980.00
- +
50mg
≥98%(HPLC)
in stock  
$2,179.00   $1,525.00
- +
100mg
≥98%(HPLC)
in stock  
$3,504.00   $2,453.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00AE8U
Chemical Name:
9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE
CAS Number:
183721-15-5
Molecular Formula:
C21H14ClN5O2
Molecular Weight:
403.8212
MDL Number:
MFCD01321046
SMILES:
O=C(Nc1nc2ccc(cc2c2n1nc(n2)c1ccco1)Cl)Cc1ccccc1
NSC Number:
695674
Properties
Computed Properties
 
Complexity:
589  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
4  
XLogP3:
3.9  

Literature

Title: Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implications.

Journal: Journal of medicinal chemistry 20120628

Title: Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters 20110515

Title: Antagonist selective modulation of adenosine A1 and A3 receptor pharmacology by the food dye Brilliant Black BN: evidence for allosteric interactions.

Journal: Molecular pharmacology 20100401

Title: Synthesis of theophylline derivatives and study of their activity as antagonists at adenosine receptors.

Journal: Bioorganic & medicinal chemistry 20100315

Title: The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophages.

Journal: British journal of pharmacology 20100301

Title: Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20091115

Title: Multiple receptor subtypes and multiple mechanisms of dilation are involved in vascular network dilation caused by adenosine.

Journal: Microvascular research 20090501

Title: Caffeine modulates TNF-alpha production by cord blood monocytes: the role of adenosine receptors.

Journal: Pediatric research 20090201

Title: Adenosine receptor subtypes in the airways responses to 5'-adenosine monophosphate inhalation of sensitized guinea-pigs.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20080901

Title: Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line.

Journal: American journal of physiology. Heart and circulatory physiology 20080601

Title: Dual purinergic synaptic transmission in the human enteric nervous system.

Journal: American journal of physiology. Gastrointestinal and liver physiology 20080201

Title: Indomethacin stimulates activity and expression of ecto-5'-nucleotidase/CD73 in glioma cell lines.

Journal: European journal of pharmacology 20070813

Title: Stimulation of adenosine A1 and A2A receptors by AMP in the submucosal plexus of guinea pig small intestine.

Journal: American journal of physiology. Gastrointestinal and liver physiology 20070201

Title: Inhibitory responses to exogenous adenosine in murine proximal and distal colon.

Journal: British journal of pharmacology 20060801

Title: Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models.

Journal: Journal of medicinal chemistry 20060713

Title: Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors.

Journal: American journal of physiology. Endocrinology and metabolism 20060501

Title: Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptors.

Journal: Autonomic & autacoid pharmacology 20060401

Title: A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro.

Journal: British journal of pharmacology 20060301

Title: Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.

Journal: The Journal of rheumatology 20050301

Title: Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats.

Journal: Epilepsia 20050101

Title: [3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors.

Journal: Biochemical pharmacology 20040715

Title: Inosine stimulates chemotaxis, Ca2+-transients and actin polymerization in immature human dendritic cells via a pertussis toxin-sensitive mechanism independent of adenosine receptors.

Journal: Journal of cellular physiology 20040401

Title: A2A and A3 receptors mediate the adenosine-induced relaxation in spontaneously active possum duodenum in vitro.

Journal: British journal of pharmacology 20030401

Title: Positive coupling of atypical adenosine A3 receptors on human eosinophils to adenylyl cyclase.

Journal: Biochemical and biophysical research communications 20030117

Title: Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons.

Journal: Restorative neurology and neuroscience 20030101

Title: Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.

Journal: Journal of medicinal chemistry 20020926

Title: 1,2,4-Triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A(3) receptor ligands.

Journal: Journal of medicinal chemistry 20020815

Title: Targeted deletion of adenosine A(3) receptors augments adenosine-induced coronary flow in isolated mouse heart.

Journal: American journal of physiology. Heart and circulatory physiology 20020601

Title: 2-Chloro-N(6)-cyclopentyladenosine, adenosine A(1) receptor agonist, antagonizes the adenosine A(3) receptor.

Journal: European journal of pharmacology 20020517

Title: p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.

Journal: Biochemical pharmacology 20020301

Title: Effects of A(3) adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart.

Journal: Cardiovascular research 20020101

Title: A3 receptors mediate rapid inflammatory cell influx into the lungs of sensitized guinea-pigs.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20010601

Title: Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.

Journal: British journal of pharmacology 20010301

Title: Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons.

Journal: Neuropharmacology 20010101

Title: Activation of the A3 adenosine receptor affects cell cycle progression and cell growth.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20000301

Title: Pharmacological characterization of novel A3 adenosine receptor-selective antagonists.

Journal: Neuropharmacology 19970901

Title: Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.

Journal: Journal of medicinal chemistry 19961011

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 183721-15-5
Tags:183721-15-5 Molecular Formula|183721-15-5 MDL|183721-15-5 SMILES|183721-15-5 9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE